Pharmaron Beijing Co., Ltd. (PHBBF)
1.93
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
Pharmaron Beijing Profit Margin (Quarterly) : 9.99% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.99% |
| March 31, 2026 | 8.67% |
| December 31, 2025 | 12.20% |
| September 30, 2025 | 11.34% |
| June 30, 2025 | 11.16% |
| March 31, 2025 | 9.02% |
| December 31, 2024 | 9.97% |
| September 30, 2024 | 8.98% |
| June 30, 2024 | 29.55% |
| March 31, 2024 | 8.18% |
| December 31, 2023 | 15.02% |
| September 30, 2023 | 12.08% |
| June 30, 2023 | 14.88% |
| March 31, 2023 | 12.94% |
| December 31, 2022 | 14.25% |
| September 30, 2022 | 13.69% |
| June 30, 2022 | 12.97% |
| Date | Value |
|---|---|
| March 31, 2022 | 11.34% |
| December 31, 2021 | 28.76% |
| September 30, 2021 | 22.65% |
| June 30, 2021 | 17.29% |
| March 31, 2021 | 15.89% |
| December 31, 2020 | 24.74% |
| September 30, 2020 | 21.51% |
| June 30, 2020 | 30.26% |
| March 31, 2020 | 9.71% |
| December 31, 2019 | 18.86% |
| September 30, 2019 | 16.24% |
| June 30, 2019 | 12.06% |
| March 31, 2019 | 6.91% |
| December 31, 2018 | 13.14% |
| September 30, 2018 | 14.16% |
| June 30, 2018 | 12.02% |
| March 31, 2018 | 6.88% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Viva Biotech Holdings | -- |
| ICON plc | 3.52% |
| Proteome Sciences Plc | -- |
| Champions Oncology, Inc. | -2.80% |
| SPO Global, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 10.07% |
| Return on Assets | 5.91% |
| Return on Invested Capital | 7.09% |
| Gross Profit Margin (Quarterly) | 31.01% |
| Operating Margin (Quarterly) | 13.23% |
| Return on Net Operating Assets | 7.49% |